This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Exelixis, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Andrew Raub - Innovator in Pharmaceutical Compounds
Introduction
Andrew Raub is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate protein kinases. His work is essential for advancing treatments for various disorders.
Latest Patents
Andrew Raub holds a patent for Pyridone compounds and methods of use. This patent relates to compounds and pharmaceutical compositions that are suitable as modulators of protein kinases. The methods described in his patent are aimed at treating disorders that are mediated, at least in part, by protein kinases. He has 1 patent to his name.
Career Highlights
Andrew Raub is currently employed at Exelixis, Inc., where he continues to innovate in the pharmaceutical sector. His work at Exelixis focuses on developing new therapeutic strategies that can improve patient outcomes.
Collaborations
Throughout his career, Andrew has collaborated with talented individuals such as Lynne Canne Bannen and Minna Bui. These collaborations have contributed to the advancement of research and development in his field.
Conclusion
Andrew Raub is a dedicated inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various disorders. His contributions to the field are noteworthy and reflect his commitment to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile